CSF1R and Alzheimer disease: In conclusion, the current study shows that microglial depletion by the CSF1R inhibitor PLX3397 prevented amyloid plaque formation and rescued the expression of synaptic plasticity-related genes in the late stage of AD in 5xFAD mice.